Andrew Cutler
Psychiatry · Lakewood Ranch, FLNPI 1063476125
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $3,910,690 of the $5,694,991 with a category attached, or 68.7%. It is spread thinly across 41 manufacturers, the largest accounting for just 15.7%. 2025 is the largest year on record at $1,137,948, 2.1 times the $553,471 reported in 2019. Among psychiatry clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 5,347 payments — averaging $1065.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$893K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$763K
- Teva Pharmaceuticals USA, Inc.$631K
- Alkermes, Inc.$625K
- Axsome Therapeutics, Inc.$485K
- Supernus Pharmaceuticals, Inc.$364K
- plus $1.9M from 35 others
Across 156 payments — averaging $15,738 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Tris Pharma Inc$1.1M
- Adlon Therapeutics L.p.$1M
- Otsuka Pharmaceutical Development & Commercialization, Inc.$160K
- Supernus Pharmaceuticals, Inc.$140K
- Arbor Pharmaceuticals, Inc.$30K
- AbbVie$17K
- plus $7K from 3 others
What the payments were for
- Consulting fees$1,161,77520%
- Speaking & faculty fees$3,910,69069%
- Grants$3,0350%
- Travel & lodging$507,8249%
- Food & beverage$103,0142%
- Education$8,6510%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$1,310,611
- ARISTADA$1,042,335
- VRAYLAR$841,174
- CAPLYTA$755,035
- Auvelity$448,912
- AUSTEDO$404,749
- INGREZZA$304,266
- REXULTI$267,871
- ARISTADA INITIO$250,353
- QELBREE$239,082
- SPRAVATO$198,493
- Fanapt$166,473
- COBENFY$113,851
- Azstarys$109,086
- Jornay PM 20mg capsules (Bottle of 100)$96,956
- UZEDY$81,705
- Austedo XR$60,033
- JORNAY PM$41,104
- BRINTELLIX$40,415
- NUPLAZID$34,769
How this compares
$5,694,991 in reported general payments places this provider in the 95th percentile of 2,059 psychiatry providers in Florida.
Other psychiatry in Lakewood Ranch
- Richard JacksonBoca Raton$3.6M
- Ilan MelnickCoral Gables$2.8M
- Todd BroderSt Augustine$1.6M
- Heather LuingSaint Augustine$1.5M
- Todd GatesWest Melbourne$1.2M
- Lawrence ReccoppaGainesville$968K
- Thomas ValenteLeesburg$967K
- Michelle ScargleClearwater$926K
- David SheehanTampa$631K
- Jose GamezHialeah$557K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.